Development of lentiviral vectors transcriptionally targeted for the treatment of human primary immunodeficiencies and other monogenic diseases. Development of gene therapy models.
Collaboration request
Full name.
Introduzca su correo electrónico
Write a contact phone.
Write your comments here.
aviso legal
RSS
